Secondary Progressive Multiple Sclerosis Drug Trial- Currently Enrolling New Patients

At North Valley Neurology & Sleep we are currently accepting new patients into a clinical drug trial for a medication for treatment of secondary progressive multiple sclerosis (SPMS). There is currently only one FDA approved treatment for SPMS, Novantrone, which is a chemotherapy drug which has serious potential side effects. The new clinical drug trial is for an oral agent (pill form) taken once a day. There is no charge to participate, and participants are compensated for their time. If you are interested, please contact our office at 602-482-2116 for more information. Eligible patients must be under 60 years old, and capable of walking 60 feet with a walker or bilateral canes/crutches.